Low Molecular Weight Heparin Market - Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 13-Jan-2022
No. of pages: 76

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

This report contains market size and forecasts of Low Molecular Weight Heparin in global, including the following market information:

Global Low Molecular Weight Heparin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Low Molecular Weight Heparin Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Low Molecular Weight Heparin companies in 2021 (%)

The global Low Molecular Weight Heparin market was valued at 348.4 million in 2021 and is projected to reach US$ 495.7 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Enoxaparin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Low Molecular Weight Heparin include Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow and Yantai Dongcheng Pharmaceutical Group. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Low Molecular Weight Heparin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Low Molecular Weight Heparin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Low Molecular Weight Heparin Market Segment Percentages, by Type, 2021 (%)

- Enoxaparin

- Dalteparin

- Tinzaparin

- Fraxiparine

Global Low Molecular Weight Heparin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Low Molecular Weight Heparin Market Segment Percentages, by Application, 2021 (%)

- Treatment of Venous Thromboembolism

- Complications of Pregnancy

- Cardioversion of Atrial Fibrillation/Flutter

- Others

Global Low Molecular Weight Heparin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Low Molecular Weight Heparin Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Low Molecular Weight Heparin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Low Molecular Weight Heparin revenues share in global market, 2021 (%)

Key companies Low Molecular Weight Heparin sales in global market, 2017-2022 (Estimated), (MT)

Key companies Low Molecular Weight Heparin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Aspen

- Sanofi-aventis

- Pfizer

- Opocrin

- CSBIO

- Dongying Tiandong Pharmaceutical

- Changzhou Qianhong Bio-pharma

- Techdow

- Yantai Dongcheng Pharmaceutical Group

Low Molecular Weight Heparin Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Low Molecular Weight Heparin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Low Molecular Weight Heparin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Low Molecular Weight Heparin Overall Market Size
2.1 Global Low Molecular Weight Heparin Market Size: 2021 VS 2028
2.2 Global Low Molecular Weight Heparin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Low Molecular Weight Heparin Sales: 2017-2028
3 Company Landscape
3.1 Top Low Molecular Weight Heparin Players in Global Market
3.2 Top Global Low Molecular Weight Heparin Companies Ranked by Revenue
3.3 Global Low Molecular Weight Heparin Revenue by Companies
3.4 Global Low Molecular Weight Heparin Sales by Companies
3.5 Global Low Molecular Weight Heparin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Low Molecular Weight Heparin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Low Molecular Weight Heparin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Low Molecular Weight Heparin Players in Global Market
3.8.1 List of Global Tier 1 Low Molecular Weight Heparin Companies
3.8.2 List of Global Tier 2 and Tier 3 Low Molecular Weight Heparin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Low Molecular Weight Heparin Market Size Markets, 2021 & 2028
4.1.2 Enoxaparin
4.1.3 Dalteparin
4.1.4 Tinzaparin
4.1.5 Fraxiparine
4.2 By Type - Global Low Molecular Weight Heparin Revenue & Forecasts
4.2.1 By Type - Global Low Molecular Weight Heparin Revenue, 2017-2022
4.2.2 By Type - Global Low Molecular Weight Heparin Revenue, 2023-2028
4.2.3 By Type - Global Low Molecular Weight Heparin Revenue Market Share, 2017-2028
4.3 By Type - Global Low Molecular Weight Heparin Sales & Forecasts
4.3.1 By Type - Global Low Molecular Weight Heparin Sales, 2017-2022
4.3.2 By Type - Global Low Molecular Weight Heparin Sales, 2023-2028
4.3.3 By Type - Global Low Molecular Weight Heparin Sales Market Share, 2017-2028
4.4 By Type - Global Low Molecular Weight Heparin Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Low Molecular Weight Heparin Market Size, 2021 & 2028
5.1.2 Treatment of Venous Thromboembolism
5.1.3 Complications of Pregnancy
5.1.4 Cardioversion of Atrial Fibrillation/Flutter
5.1.5 Others
5.2 By Application - Global Low Molecular Weight Heparin Revenue & Forecasts
5.2.1 By Application - Global Low Molecular Weight Heparin Revenue, 2017-2022
5.2.2 By Application - Global Low Molecular Weight Heparin Revenue, 2023-2028
5.2.3 By Application - Global Low Molecular Weight Heparin Revenue Market Share, 2017-2028
5.3 By Application - Global Low Molecular Weight Heparin Sales & Forecasts
5.3.1 By Application - Global Low Molecular Weight Heparin Sales, 2017-2022
5.3.2 By Application - Global Low Molecular Weight Heparin Sales, 2023-2028
5.3.3 By Application - Global Low Molecular Weight Heparin Sales Market Share, 2017-2028
5.4 By Application - Global Low Molecular Weight Heparin Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Low Molecular Weight Heparin Market Size, 2021 & 2028
6.2 By Region - Global Low Molecular Weight Heparin Revenue & Forecasts
6.2.1 By Region - Global Low Molecular Weight Heparin Revenue, 2017-2022
6.2.2 By Region - Global Low Molecular Weight Heparin Revenue, 2023-2028
6.2.3 By Region - Global Low Molecular Weight Heparin Revenue Market Share, 2017-2028
6.3 By Region - Global Low Molecular Weight Heparin Sales & Forecasts
6.3.1 By Region - Global Low Molecular Weight Heparin Sales, 2017-2022
6.3.2 By Region - Global Low Molecular Weight Heparin Sales, 2023-2028
6.3.3 By Region - Global Low Molecular Weight Heparin Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Low Molecular Weight Heparin Revenue, 2017-2028
6.4.2 By Country - North America Low Molecular Weight Heparin Sales, 2017-2028
6.4.3 US Low Molecular Weight Heparin Market Size, 2017-2028
6.4.4 Canada Low Molecular Weight Heparin Market Size, 2017-2028
6.4.5 Mexico Low Molecular Weight Heparin Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Low Molecular Weight Heparin Revenue, 2017-2028
6.5.2 By Country - Europe Low Molecular Weight Heparin Sales, 2017-2028
6.5.3 Germany Low Molecular Weight Heparin Market Size, 2017-2028
6.5.4 France Low Molecular Weight Heparin Market Size, 2017-2028
6.5.5 U.K. Low Molecular Weight Heparin Market Size, 2017-2028
6.5.6 Italy Low Molecular Weight Heparin Market Size, 2017-2028
6.5.7 Russia Low Molecular Weight Heparin Market Size, 2017-2028
6.5.8 Nordic Countries Low Molecular Weight Heparin Market Size, 2017-2028
6.5.9 Benelux Low Molecular Weight Heparin Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Low Molecular Weight Heparin Revenue, 2017-2028
6.6.2 By Region - Asia Low Molecular Weight Heparin Sales, 2017-2028
6.6.3 China Low Molecular Weight Heparin Market Size, 2017-2028
6.6.4 Japan Low Molecular Weight Heparin Market Size, 2017-2028
6.6.5 South Korea Low Molecular Weight Heparin Market Size, 2017-2028
6.6.6 Southeast Asia Low Molecular Weight Heparin Market Size, 2017-2028
6.6.7 India Low Molecular Weight Heparin Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Low Molecular Weight Heparin Revenue, 2017-2028
6.7.2 By Country - South America Low Molecular Weight Heparin Sales, 2017-2028
6.7.3 Brazil Low Molecular Weight Heparin Market Size, 2017-2028
6.7.4 Argentina Low Molecular Weight Heparin Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Low Molecular Weight Heparin Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Low Molecular Weight Heparin Sales, 2017-2028
6.8.3 Turkey Low Molecular Weight Heparin Market Size, 2017-2028
6.8.4 Israel Low Molecular Weight Heparin Market Size, 2017-2028
6.8.5 Saudi Arabia Low Molecular Weight Heparin Market Size, 2017-2028
6.8.6 UAE Low Molecular Weight Heparin Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Aspen
7.1.1 Aspen Corporate Summary
7.1.2 Aspen Business Overview
7.1.3 Aspen Low Molecular Weight Heparin Major Product Offerings
7.1.4 Aspen Low Molecular Weight Heparin Sales and Revenue in Global (2017-2022)
7.1.5 Aspen Key News
7.2 Sanofi-aventis
7.2.1 Sanofi-aventis Corporate Summary
7.2.2 Sanofi-aventis Business Overview
7.2.3 Sanofi-aventis Low Molecular Weight Heparin Major Product Offerings
7.2.4 Sanofi-aventis Low Molecular Weight Heparin Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi-aventis Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Low Molecular Weight Heparin Major Product Offerings
7.3.4 Pfizer Low Molecular Weight Heparin Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Opocrin
7.4.1 Opocrin Corporate Summary
7.4.2 Opocrin Business Overview
7.4.3 Opocrin Low Molecular Weight Heparin Major Product Offerings
7.4.4 Opocrin Low Molecular Weight Heparin Sales and Revenue in Global (2017-2022)
7.4.5 Opocrin Key News
7.5 CSBIO
7.5.1 CSBIO Corporate Summary
7.5.2 CSBIO Business Overview
7.5.3 CSBIO Low Molecular Weight Heparin Major Product Offerings
7.5.4 CSBIO Low Molecular Weight Heparin Sales and Revenue in Global (2017-2022)
7.5.5 CSBIO Key News
7.6 Dongying Tiandong Pharmaceutical
7.6.1 Dongying Tiandong Pharmaceutical Corporate Summary
7.6.2 Dongying Tiandong Pharmaceutical Business Overview
7.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Major Product Offerings
7.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales and Revenue in Global (2017-2022)
7.6.5 Dongying Tiandong Pharmaceutical Key News
7.7 Changzhou Qianhong Bio-pharma
7.7.1 Changzhou Qianhong Bio-pharma Corporate Summary
7.7.2 Changzhou Qianhong Bio-pharma Business Overview
7.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Major Product Offerings
7.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales and Revenue in Global (2017-2022)
7.7.5 Changzhou Qianhong Bio-pharma Key News
7.8 Techdow
7.8.1 Techdow Corporate Summary
7.8.2 Techdow Business Overview
7.8.3 Techdow Low Molecular Weight Heparin Major Product Offerings
7.8.4 Techdow Low Molecular Weight Heparin Sales and Revenue in Global (2017-2022)
7.8.5 Techdow Key News
7.9 Yantai Dongcheng Pharmaceutical Group
7.9.1 Yantai Dongcheng Pharmaceutical Group Corporate Summary
7.9.2 Yantai Dongcheng Pharmaceutical Group Business Overview
7.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Major Product Offerings
7.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales and Revenue in Global (2017-2022)
7.9.5 Yantai Dongcheng Pharmaceutical Group Key News
8 Global Low Molecular Weight Heparin Production Capacity, Analysis
8.1 Global Low Molecular Weight Heparin Production Capacity, 2017-2028
8.2 Low Molecular Weight Heparin Production Capacity of Key Manufacturers in Global Market
8.3 Global Low Molecular Weight Heparin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Low Molecular Weight Heparin Supply Chain Analysis
10.1 Low Molecular Weight Heparin Industry Value Chain
10.2 Low Molecular Weight Heparin Upstream Market
10.3 Low Molecular Weight Heparin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Low Molecular Weight Heparin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Low Molecular Weight Heparin in Global Market
Table 2. Top Low Molecular Weight Heparin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Low Molecular Weight Heparin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Low Molecular Weight Heparin Revenue Share by Companies, 2017-2022
Table 5. Global Low Molecular Weight Heparin Sales by Companies, (MT), 2017-2022
Table 6. Global Low Molecular Weight Heparin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Low Molecular Weight Heparin Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Low Molecular Weight Heparin Product Type
Table 9. List of Global Tier 1 Low Molecular Weight Heparin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Low Molecular Weight Heparin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Low Molecular Weight Heparin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Low Molecular Weight Heparin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Low Molecular Weight Heparin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Low Molecular Weight Heparin Sales (MT), 2017-2022
Table 15. By Type - Global Low Molecular Weight Heparin Sales (MT), 2023-2028
Table 16. By Application - Global Low Molecular Weight Heparin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Low Molecular Weight Heparin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Low Molecular Weight Heparin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Low Molecular Weight Heparin Sales (MT), 2017-2022
Table 20. By Application - Global Low Molecular Weight Heparin Sales (MT), 2023-2028
Table 21. By Region - Global Low Molecular Weight Heparin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Low Molecular Weight Heparin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Low Molecular Weight Heparin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Low Molecular Weight Heparin Sales (MT), 2017-2022
Table 25. By Region - Global Low Molecular Weight Heparin Sales (MT), 2023-2028
Table 26. By Country - North America Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Low Molecular Weight Heparin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Low Molecular Weight Heparin Sales, (MT), 2017-2022
Table 29. By Country - North America Low Molecular Weight Heparin Sales, (MT), 2023-2028
Table 30. By Country - Europe Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Low Molecular Weight Heparin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Low Molecular Weight Heparin Sales, (MT), 2017-2022
Table 33. By Country - Europe Low Molecular Weight Heparin Sales, (MT), 2023-2028
Table 34. By Region - Asia Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Low Molecular Weight Heparin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Low Molecular Weight Heparin Sales, (MT), 2017-2022
Table 37. By Region - Asia Low Molecular Weight Heparin Sales, (MT), 2023-2028
Table 38. By Country - South America Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Low Molecular Weight Heparin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Low Molecular Weight Heparin Sales, (MT), 2017-2022
Table 41. By Country - South America Low Molecular Weight Heparin Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Low Molecular Weight Heparin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Low Molecular Weight Heparin Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Low Molecular Weight Heparin Sales, (MT), 2023-2028
Table 46. Aspen Corporate Summary
Table 47. Aspen Low Molecular Weight Heparin Product Offerings
Table 48. Aspen Low Molecular Weight Heparin Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Sanofi-aventis Corporate Summary
Table 50. Sanofi-aventis Low Molecular Weight Heparin Product Offerings
Table 51. Sanofi-aventis Low Molecular Weight Heparin Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Low Molecular Weight Heparin Product Offerings
Table 54. Pfizer Low Molecular Weight Heparin Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Opocrin Corporate Summary
Table 56. Opocrin Low Molecular Weight Heparin Product Offerings
Table 57. Opocrin Low Molecular Weight Heparin Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. CSBIO Corporate Summary
Table 59. CSBIO Low Molecular Weight Heparin Product Offerings
Table 60. CSBIO Low Molecular Weight Heparin Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Dongying Tiandong Pharmaceutical Corporate Summary
Table 62. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Offerings
Table 63. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Changzhou Qianhong Bio-pharma Corporate Summary
Table 65. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Offerings
Table 66. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Techdow Corporate Summary
Table 68. Techdow Low Molecular Weight Heparin Product Offerings
Table 69. Techdow Low Molecular Weight Heparin Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Yantai Dongcheng Pharmaceutical Group Corporate Summary
Table 71. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Offerings
Table 72. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Low Molecular Weight Heparin Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 74. Global Low Molecular Weight Heparin Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Low Molecular Weight Heparin Production by Region, 2017-2022 (MT)
Table 76. Global Low Molecular Weight Heparin Production by Region, 2023-2028 (MT)
Table 77. Low Molecular Weight Heparin Market Opportunities & Trends in Global Market
Table 78. Low Molecular Weight Heparin Market Drivers in Global Market
Table 79. Low Molecular Weight Heparin Market Restraints in Global Market
Table 80. Low Molecular Weight Heparin Raw Materials
Table 81. Low Molecular Weight Heparin Raw Materials Suppliers in Global Market
Table 82. Typical Low Molecular Weight Heparin Downstream
Table 83. Low Molecular Weight Heparin Downstream Clients in Global Market
Table 84. Low Molecular Weight Heparin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Low Molecular Weight Heparin Segment by Type
Figure 2. Low Molecular Weight Heparin Segment by Application
Figure 3. Global Low Molecular Weight Heparin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Low Molecular Weight Heparin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Low Molecular Weight Heparin Revenue, 2017-2028 (US$, Mn)
Figure 7. Low Molecular Weight Heparin Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Low Molecular Weight Heparin Revenue in 2021
Figure 9. By Type - Global Low Molecular Weight Heparin Sales Market Share, 2017-2028
Figure 10. By Type - Global Low Molecular Weight Heparin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Low Molecular Weight Heparin Price (USD/MT), 2017-2028
Figure 12. By Application - Global Low Molecular Weight Heparin Sales Market Share, 2017-2028
Figure 13. By Application - Global Low Molecular Weight Heparin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Low Molecular Weight Heparin Price (USD/MT), 2017-2028
Figure 15. By Region - Global Low Molecular Weight Heparin Sales Market Share, 2017-2028
Figure 16. By Region - Global Low Molecular Weight Heparin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Low Molecular Weight Heparin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Low Molecular Weight Heparin Sales Market Share, 2017-2028
Figure 19. US Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Low Molecular Weight Heparin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Low Molecular Weight Heparin Sales Market Share, 2017-2028
Figure 24. Germany Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 25. France Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Low Molecular Weight Heparin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Low Molecular Weight Heparin Sales Market Share, 2017-2028
Figure 33. China Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 37. India Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Low Molecular Weight Heparin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Low Molecular Weight Heparin Sales Market Share, 2017-2028
Figure 40. Brazil Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Low Molecular Weight Heparin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Low Molecular Weight Heparin Sales Market Share, 2017-2028
Figure 44. Turkey Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Low Molecular Weight Heparin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Low Molecular Weight Heparin Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Low Molecular Weight Heparin by Region, 2020 VS 2027
Figure 50. Low Molecular Weight Heparin Industry Value Chain
Figure 51. Marketing Channels
  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs